Insufficient early detection of peripheral neurovasculopathy and associated factors in rural diabetes residents of Taiwan: a cross-sectional study

BMC Endocrine Disorders

Mei-Yen Chen²  Chyong-Fang Chang¹  Mei-Yu Pan²  Chang-Cheng Chang³  Chia-Mou Lee¹ 

[1] Department of Nursing, Min-Hwei College of Health Care Management, Tainan City, Taiwan;College of Nursing, Chang Gung University of Science and Technology, No. 2, Chia-pu Rd. West Sec, Putz City, Chiayi County 61363, Taiwan;Division of Plastic Surgery, Chang Gung Memorial Hospital, Putz City, Chiayi County, Taiwan

关键词: Peripheral vasculopathy;    Peripheral neuropathy;    Diabetic foot ulcer;    Type 2 diabetes mellitus;   

Others  :  1084783
DOI  :  10.1186/1472-6823-14-89

 received in 2014-02-08, accepted in 2014-11-17,  发布年份 2014

【 摘 要 】

Background

Diabetic peripheral neuropathy (PN) and peripheral vasculopathy (PV) are major causes of foot ulcers in patients with diabetes. The early detection of PN/PV with appropriate health counseling is the best strategy for preventing foot lesions. The objective of this study is to examine the prevalence and associated risk factors of PN/PV among rural community residents with type 2 diabetes mellitus (T2DM).

Methods

This cross-sectional descriptive study was conducted in Taiwan from February to October 2012. Type 2 diabetes mellitus and health promotion scale, Michigan neuropathy screening instrument, and ankle-brachial pressure index values were measured.

Results

A total of 404 (55% women) participated in and completed the program. The overall prevalence of PN and PV was 34.5 and 17.1%, respectively. The majority of the participants (90%) did not receive early PN/PV detection by health care providers. After adjustment for the potential confounding factors, multivariate analysis indicated that the factors determining PN/PV were age (P <0.001), living around sea coastal regions (P <0.001), high HbA1C level (P <0.01), and fewer regular health-promoting behaviors (P <0.01).

Conclusion

There was a high prevalence of PN/PV among rural T2DM residents who received insufficient early detection. The early detection of PN/PV and provision of health education with customized health-promoting behaviors of people with diabetes in the rural community are important issues.

【 授权许可】

   
2014 Lee et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]World Health Organization, WHO: Diabetes. 2014. Available at: http://www.who.int/mediacentre/factsheets/fs312/en/index.html webcite
• [2]Department of Health (DOH), Executive Yuan, ROC, Taiwan: Cause of death statistics. 2013. Available at: http://www.mohw.gov.tw/cht/DOS/Statistic.aspx?f_list_no=312&fod_list_no=2747 webcite
• [3]Lipsky BA, Berendt AR, Deery HG, Embil JM, Joseph WS, Karchmer AW: Diagnosis and treatment of diabetic foot infections. Plast Reconstr Surg 2006, 117:212S-238S.
• [4]Zgonis T, Stapleton JJ, Girard-Powell VA, Hagino RT: Surgical management of diabetic foot infections and amputations. AORN J 2008, 87:935-950.
• [5]Bowering CK: Diabetic foot ulcers: Pathophysiology, assessment, and therapy. Can Fam Physician 2001, 47:1007-1016.
• [6]Li CM, Chang CC, Chen CM, Lai LJ, Chen MY: The devil is in the detail: prevention of diabetic foot ulceration in rural areas is possible. Open J Nurs 2013, 3:257-264.
• [7]Tesfaye S, Chaturvedi N, EMS, Ward JD: Vascular risk factors and diabetic neuropathy. Engl J Med 2005, 352:341-350.
• [8]Fard AS, Esmaelzadeh M, Larijani B: Assessment and treatment of diabetic foot ulcer. Int J Clin Pra 2007, 61:1931-1938.
• [9]Faglia E, Clerici G, Clerissi J, Gabrielli L, Losa S, Mantero M: Long-term prognosis of diabetic patients with critical limb ischemia: a population-based cohort study. Diabetes Care 2009, 32:822-827.
• [10]Alzamora MT, Forés R, Baena-Díez JM, Pera G, Toran P, Sorribes M: The peripheral arterial disease study: prevalence and risk factors in the general population. BMC Public Health 2010, 10:38-48. BioMed Central Full Text
• [11]Chen MY, Huang WC, Peng YS, Guo JS, Chen CP, Jong MC: Effectiveness of a health promotion programme for farmers and fishermen with type-2 diabetes in Taiwan. J Adv Nurs 2011, 67:2060-2067.
• [12]American Diabetes Association, ADA: Clinical practice recommendations. Diabetes Care 2011, 34:S11-S61.
• [13]Gordois A, Scuffham P, Shearer A, Oglesby A, Tobian JA: The health care costs of diabetic peripheral neuropathy in the U.S. Diabetes Care 2003, 26:1790-1795.
• [14]Williams DT, Harding KG, Price P: An evaluation of the efficacy of methods used in screening for lower-limb arterial disease in diabetes. Diabetes Care 2005, 28:2206-2210.
• [15]Chang CH, Peng YS, Chang CC, Chen MY: Useful screening tools for preventing foot problems of diabetics in rural areas: a cross-sectional study. BMC Public Health 2013, 13:612. BioMed Central Full Text
• [16]Dunning T: Nursing Care of Older People with Diabetes. Australia: Blackwell Publishing; 2008:164-167.
• [17]Fujiwara Y, Kishida K, Terao M, Takahara M, Matsuhisa M: Beneficial effects of foot care nursing for people with diabetes mellitus: an uncontrolled before and after intervention study. J Adv Nurs 2011, 67:1952-1962.
• [18]McNeely MJ, Boyko EJ, Ahroni JH, Stensel VL, Reiber GE, Smith DG: The independent contributions of diabetic neuropathy and vasculopathy in foot ulceration. How great are the risks? Diabetes Care 1995, 18:216-219.
• [19]Nather A, Chionh SB, Tay PL, Azi Z, Teng JW, Rajeswari K, Erasmus A: Foot screening for diabetics. Ann Acad Med Singapore 2010, 39:472-475.
• [20]Singh N, Armstrong DG, Lipsky BA: Preventing foot ulcers in patients with diabetes. JAMA 2005, 293:217-228.
• [21]Faul F, Erdfelder E, Lang AG, Buchner A: G Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2007, 39:175-191.
• [22]Moghtaderi A, Bakhshipour A, Rashidi H: Validation of Michigan neuropathy screening instrument for diabetic peripheral neuropathy. Clin Neurol Neurosurg 2006, 108:477-481.
• [23]Feng Y, Schlösser FJ, Sumpio BE: The Semmes Weinstein monofilament examination as a screening tool for diabetic peripheral neuropathy. J Vasc Surg 2009, 50:675.
• [24]Health Promotion Administration, Ministry of Health and Welfare: Diabetes. 2014. Available at: http://www.hpa.gov.tw/BHPNet/Web/HealthTopic/Topic.aspx?id=200712250014 webcite
• [25]Chen CP, Peng YS, Weng HS, Chen MY: Health-promoting behavior is positively associated with diabetic control among type 2 diabetes patients. Open J Nurs 2013, 3:274-280.
• [26]Chen CP, Peng YS, Weng HH, Fang JY, Chen MY: Development and preliminary testing of a brief screening measure of healthy lifestyle for diabetes patients. Int J Nurs Stud 2013, 50:90-99.
• [27]Geerts M, Bours GJJ, de Wit R, Landewe SAN, van Haarlem A, Schaper NC: Prevalence and impact of pain in diabetic neuropathy. Eur Diab Nurs 2009, 6:58-64.
• [28]Rhee SY, Guan H, Liu ZM, Cheng SW, Waspadji S, Palmes P: Multi-country study on the prevalence and clinical features of peripheral arterial disease in Asian type 2 diabetes patients at high risk of atherosclerosis. Diab Res Clin Pract 2007, 76:82-92.
• [29]Tseng CH: Prevalence and risk factors of peripheral arterial obstructive disease in Taiwanese type 2 diabetic patients. Angiology 2003, 54:331-338.
• [30]Huang TT, Guo SE, Huang JC, Li CM, Chen MY: Misperception among rural community diabetic residents. J Adv Nurs 2013, 69:927-934.